EP0732921A4 - C-glykosidanologe von n-(4-hydroxyphenyl)retinamid-o-glukuronid - Google Patents

C-glykosidanologe von n-(4-hydroxyphenyl)retinamid-o-glukuronid

Info

Publication number
EP0732921A4
EP0732921A4 EP95935115A EP95935115A EP0732921A4 EP 0732921 A4 EP0732921 A4 EP 0732921A4 EP 95935115 A EP95935115 A EP 95935115A EP 95935115 A EP95935115 A EP 95935115A EP 0732921 A4 EP0732921 A4 EP 0732921A4
Authority
EP
European Patent Office
Prior art keywords
retinamide
glucuronide
hydroxyphenyl
glycoside analogues
glycoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95935115A
Other languages
English (en)
French (fr)
Other versions
EP0732921A1 (de
Inventor
Robert W Curley Jr
Michael J Robarge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University Research Foundation
Original Assignee
Ohio State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/316,140 external-priority patent/US5516792A/en
Application filed by Ohio State University Research Foundation filed Critical Ohio State University Research Foundation
Publication of EP0732921A1 publication Critical patent/EP0732921A1/de
Publication of EP0732921A4 publication Critical patent/EP0732921A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP95935115A 1994-09-30 1995-09-26 C-glykosidanologe von n-(4-hydroxyphenyl)retinamid-o-glukuronid Withdrawn EP0732921A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US316140 1994-09-30
US08/316,140 US5516792A (en) 1992-11-13 1994-09-30 C-glycoside analogues of N-(4-hydroxyphenyl)retinamide-O-glucuronide
US321207 1994-10-07
US08/321,207 US5574177A (en) 1992-11-13 1994-10-07 Arylamide analogues of N-(4-hydroxyphenyl) retinamide-o-glucuronide
PCT/US1995/012258 WO1996013258A1 (en) 1994-09-30 1995-09-26 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide

Publications (2)

Publication Number Publication Date
EP0732921A1 EP0732921A1 (de) 1996-09-25
EP0732921A4 true EP0732921A4 (de) 1998-09-02

Family

ID=26980259

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95935115A Withdrawn EP0732921A4 (de) 1994-09-30 1995-09-26 C-glykosidanologe von n-(4-hydroxyphenyl)retinamid-o-glukuronid

Country Status (3)

Country Link
EP (1) EP0732921A4 (de)
JP (1) JPH09509680A (de)
WO (1) WO1996013258A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117845A (en) * 1999-06-11 2000-09-12 Ohio State University Research Foundation C-linked analogs of N-(4-hydroxyphenyl) retinamide
WO2003018598A2 (en) * 2001-08-30 2003-03-06 University College Dublin Monosaccharide derivatives
AR056195A1 (es) * 2005-09-15 2007-09-26 Boehringer Ingelheim Int Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
MX2010002695A (es) 2007-09-10 2010-04-01 Janssen Pharmaceutica Nv Proceso para la preparacion de compuestos utiles como inhibidores de transportador de glucosa dependiente de sodio (sglt).
US9056850B2 (en) 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
SI2488515T1 (sl) 2009-10-14 2017-04-26 Janssen Pharmaceutica Nv Postopek za pripravo spojin, ki so uporabne kot inhibitorji SGLT2
TWI599360B (zh) 2010-05-11 2017-09-21 健生藥品公司 醫藥調配物
RS55056B1 (sr) 2011-04-13 2016-12-30 Janssen Pharmaceutica Nv Proces za pripremu jedinjenja koja su korisna kao inhibitori sglt2
TWI542596B (zh) 2011-05-09 2016-07-21 健生藥品公司 (2s,3r,4r,5s,6r)-2-(3-((5-(4-氟苯基)噻吩-2-基)甲基)-4-甲基苯基)-6-(羥甲基)四氫-2h-哌喃-3,4,5-三醇之l-脯胺酸及檸檬酸共晶體

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011030A1 (en) * 1992-11-13 1994-05-26 The Ohio State University Research Foundation C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011030A1 (en) * 1992-11-13 1994-05-26 The Ohio State University Research Foundation C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PANIGOT M J ET AL: "PREPARATION OF 4-RETINAMIDOPHENYL- AND 4-RETINAMIDOBENZYL-C- GLYCOSYL AND C-GLUCURONOSYL ANALOGUES OF THE GLUCURONIDE OF 4-HYDROXYPHENYL-RETINAMIDE AS POTENTIAL STABLE CANCER CHEMOPREVENTIVE AGENTS", JOURNAL OF CARBOHYDRATE CHEMISTRY, vol. 13, no. 2, 1 January 1994 (1994-01-01), pages 303 - 321, XP000562292 *
ROBARGE M J ET AL: "N-LINKED ANALOGS OF RETINOID O-FLUCURONIDES: POTENTIAL CANCER CHEMOPREVENTIVE/CHEMOTHERAPEUTIC AGENTS", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 4, no. 17, 8 September 1994 (1994-09-08), pages 2117 - 2122, XP000561553 *
See also references of WO9613258A1 *

Also Published As

Publication number Publication date
EP0732921A1 (de) 1996-09-25
JPH09509680A (ja) 1997-09-30
WO1996013258A1 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
PL320644A1 (en) Acylated insulin analogues
GB2296354B (en) Multithreaded processor
DE69413427D1 (de) Geformte Kopfbänderung
GR3029893T3 (en) N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists
AU120920S (en) Oscillating sprinkler
PL313741A1 (en) Intervulcanisable mixtures of elastomers
AU122709S (en) Kneader massager
ZA957113B (en) Use of N-substituted pyhenothiazines
EP0732921A4 (de) C-glykosidanologe von n-(4-hydroxyphenyl)retinamid-o-glukuronid
ZA959996B (en) Enterokinetic benzamide
PL312663A1 (en) Method of manufacturing n-(4-hydroxyphenyl)-retinamide
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
IT1269916B (it) Procedimento migliorato per la sintesi di dimetilcarbonato
GB2265623B (en) Preparation of n-vinyl-o-alkyl carbamate
CA2120874A1 (en) Form 1 ranitidine form
PL319351A1 (en) Epimers of (22rs)-n-(1,1,1-trifluoro-2-phenyprop-2-y)-3-oxo-4-aza-5a-androst-1-ene-17b carboxylamide
ZA9711465B (en) Salts of acetaminophen
GB9321345D0 (en) Instant nail mask
GB2294064B (en) Low modulus of elasticity lintel
PL303253A1 (en) Novel alkyammonium salts - derivatives of substituted benzylamine
PL303254A1 (en) Novel alkoxymethylammonium chlorides - derivatives of substituted benzylamine
GB9411032D0 (en) Synthesis of substituted diaminophthalimides and analogues
GB9426449D0 (en) Use of triphenylethylene compounds
CS275222B2 (en) Analogues of deamino-vasopressin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960619

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: C07H 13/04

A4 Supplementary search report drawn up and despatched

Effective date: 19980713

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20010117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010728